Lori A. Gressick
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 14
- Chronic Lymphocytic Leukemia Research 14
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Matthew S. Davids (14 shared papers)Andrew W. Roberts (14 shared papers)Mary Ann Anderson (11 shared papers)Rod Humerickhouse (11 shared papers)John F. Seymour (13 shared papers)John M. Pagel (11 shared papers)John F. Gerecitano (12 shared papers)Brad S. Kahl (11 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Blood (6 papers)Hematological Oncology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Lori A. Gressick
14 papers receiving 1.7k citations
Lori A. Gressick's Hit Papers
Peers
Comparison fields: 5 of 69
- Genetics 1.1k
- Pathology and Forensic Medicine 721
- Hematology 416
- Oncology 436
- Immunology 327
Countries citing papers authored by Lori A. Gressick
This map shows the geographic impact of Lori A. Gressick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori A. Gressick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori A. Gressick more than expected).
Fields of papers citing papers by Lori A. Gressick
This network shows the impact of papers produced by Lori A. Gressick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori A. Gressick. The network helps show where Lori A. Gressick may publish in the future.
Co-authors
The 25 scholars most cited alongside Lori A. Gressick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia Hit paper breakdown → | 2015 | 1360 |
| 2 | 2014 | 75 | |
| 3 | 2015 | 60 | |
| 4 | 2013 | 56 | |
| 5 | 2014 | 43 | |
| 6 | 2013 | 42 | |
| 7 | 2014 | 38 | |
| 8 | 2012 | 28 | |
| 9 | 2013 | 20 | |
| 10 | 2016 | 11 | |
| 11 | 2013 | 10 | |
| 12 | 2012 | 6 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 1 |
About Lori A. Gressick
Lori A. Gressick is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 14 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (8 papers), Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Genetics (1.1k citations), Pathology and Forensic Medicine (721 citations), Hematology (416 citations), Oncology (436 citations) and Immunology (327 citations). Lori A. Gressick has collaborated with scholars based in United States and Australia. Frequent co-authors include Matthew S. Davids, Andrew W. Roberts, Mary Ann Anderson, Rod Humerickhouse, John F. Seymour, John M. Pagel, John F. Gerecitano, Brad S. Kahl, William G. Wierda and Sari H. Enschede. Their work appears in journals such as Journal of Clinical Oncology, Blood, Hematological Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.